SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-04-134489
Filing Date
2004-08-06
Accepted
2004-08-06 17:10:11
Documents
6
Effectiveness Date
2004-08-06

Document Format Files

Seq Description Document Type Size
1 FORM S-8 ds8.htm S-8 52567
2 CELL THERAPEUTICS, INC. 2003 EQUITY INCENTIVE PLAN, AS AMENDED dex41.htm EX-4.1 164283
3 CELL THERAPEUTICS, INC. 1996 EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED dex42.htm EX-4.2 35886
4 OPINION OF WILSON SONSINI GOODRICH & ROSATI dex51.htm EX-5.1 4415
5 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1900
6 CONSENT OF RECONTA ERNST & YOUNG S.P.A. dex232.htm EX-23.2 1681
  Complete submission text file 0001193125-04-134489.txt   262941
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-118016 | Film No.: 04958780
SIC: 2834 Pharmaceutical Preparations